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The prevalence of Helicobacter pylori carrier rates
among the healthy blood donors in Hong Kong
C. K. Ching, S. T. Yuen, I. S. C. Luk, J. Ho and S. K. Lam
Abstract
A serological assay was employed in this study to assess the Helicobacter pylori carrier rates among
the healthy blood donors (all Chinese) in Hong Kong. The commercial kit for detecting anti-H.
pylori antibody titres was found to have a sensitivity of 84% and a specificity of 85% by using the
histochemistry results as the gold standard. Elevated anti-H. pylori antibody titres were observed
in 42.4%, 53.2% and 72.2% of the healthy blood donors of age below 20, 21 to 30 and 31 to 40 years
respectively. This indicates a steady rise of H. pylori carrier rates with age. The overall H. pylori
prevalence rate was 54.9%. The positivity of H. pylori in teenagers appeared to be double that
reported in Western countries. Whether this is related to the younger age of peptic ulcer presenta-
tion in Hong Kong compared with Western countries is not known. However, there was no
significant difference of the H. pylori rates between males and females of each age group al-
though a male predominance has been well established for peptic ulcer in Hong Kong.
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Introduction
Peptic ulcer disease is a common ailment among the
Chinese in Hong Kong. Approximately one in 10
adults suffers from peptic ulcer disease during any
period of time. It is one of the major reasons for
taking sick leave in our society. Previous studies have
demonstrated ulcer relapse rate could be higher than
50% if no maintenance therapy is given after success-
ful treatment by using ulcer healing agents such as
H2-receptor antagonist or omeprazole.1, 2 In our expe-
rience, the great majority (>95%) of duodenal ulcer
patients in Hong Kong has Helicobacter pylori (H. pylori)
infection.3 H. pylori infection is now widely accepted
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as one of the major permissive factors in the develop-
ment of peptic ulcer disease, particularly duodenal
ulcer disease.4-6 Furthermore, there is now a reported
link between H. pylori and gastric cancer7, 8 as well as
B-cell lymphoma.9 The enthusiasts would advocate
eradication of the organism in all the infected people
to prolong peptic ulcer remission rate and further-
more try and reduce the incidence of gastric cancer in
the regions where gastric cancer and H, pylori infection
are highly prevalent. Although we know peptic ulcer
disease is common in Hong Kong, we have no con-
firmed report of the overall prevalence rate of H. pylori
infection in our community. We have therefore carried
out a retrospective study on the stored healthy blood
donor sera to estimate the prevalence rate of H. pylori
infection among the Chinese in Hong Kong.
Materials and methods
Patients and histopathology
Thirty patients with duodenal ulcer disease (DU) and
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68 patients with a final diagnosis of non-ulcer dys-
pepsia were subjected to antral biopsies (x 2) which
were taken within 5 cm from the pylorus. These biop-
sies were fixed in formalin and subsequently sectioned
and stained by both haematoxylin and eosin and
warthin starry staining techniques to assess the pres-
ence of gastritis and/or H. pylori. The histology results
were used as the gold standard for the determination
of the sensitivity and the specificity of the commercial
ELISA for H. pylori diagnosis. Ten millilitres of blood
sample was obtained from each patient and the sera
stored at -20 C until required. Stored blood donor sera
(282 males, mean age of 28 and range 16 to 65 years;
177 females, mean age of 25 and range 16 to 56 years)
from the year 1991 were generous gifts of the Red
Cross Hong Kong with the consent of the donors.
Unfortunately/ apart from the age and sex, the other
demographic data were withheld due to confidential-
ity reason. Hence we were unable to demonstrate any
correlation between H. pylori infection rates and other
socio-economic factors.
Enzyme-linked immunosorbent assay (ELISA)
A commercially available anti-H. pylori (GAP-IgG,
Biomerica, Newport Beach, CA) kit was used in this
study. Crude H. pylori surface proteins are used as
coating antigens in this assay kit. The assay was
evaluated by the company to have a sensitivity of
99.4% and a specificity of 93.5%. Furthermore, the
accuracy was claimed to be 97.4%. The intraplate and
interplate variations were shown to be < 12% (7 to
11.2%) and < 14% (7.2 to 13.7%) respectively. Less
than 1%) cross reactivity rate was demonstrated against
the bacteria Campylobacter jejuni, Campylobacter coli,
Campylobacter fetus and £. coli. All the sera obtained
for this study were tested for the presence of elevated
anti-H. pylori IgG antibody by using this commercial
ELISA kit. The procedure was carried out according
to the manufacturer's recommendations. Internal
standards were provided for calibration and used as
the reference to determine the levels of anti-H. pylori
IgG. A positive result at 1:200 dilution of the serum
was regarded as a positive test. The ELISA was per-
formed by a technician who was blinded to the clini-
cal diagnosis.
Statistics
Chi square test was used to assess the difference in H.
pylori infection between the male blood donors and
the female blood donors. A p value of < 0.05 was
accepted as significant difference.
Results
Histopathology
H. pylori organisms were observed in 29/30 (97%)
duodenal ulcer patients by histochemistry. Gastritis
was present in all these 29 cases. The remaining one
patient was found to have neither gastritis nor H. pylori
infection. Among the 68 patients with non-ulcer dys-
pepsia, 35 (51.5%) was found to have H. pylori
infection. Similarly, gastritis was always present in
the H. pylori infected gastric mucosa. In the remaining
33 H. pylori negative patients, only five were observed
to have mild gastritis.
GAP-IgG ELISA
Elevated anti-H. pylori antibody titres (GAP-IgG lev-
els) were observed in 25/29 and 29/35 H. pylori
positive duodenal ulcer and non-ulcer dyspepsia pa-
tients respectively. The overall sensitivity of the
GAP-IgG ELISA was therefore only 84%. There was a
false positive rate of 15% giving the specificity of this
assay of 85%. The positive and negative predictive
value of this assay was 91.5% and 74% respectively.
H. pylori carrier rales in healthy blood donors
The distribution of the blood donors and their H. pylori
status are shown in Table 1. The overall H. pylori
prevalence in this random sample was 54.9%. When
they were stratified according to age there was a gen-
Table 1. The Helicobacter pylori positive rates of different age group in the healthy blood donors of Hong Kong.
Age (yrs.) Males (M) Females (F) M+ (%) F+ Mean+
16-20
21-30
31-40
41-65
14
83
47
12
25
72
18
11
25
50
18
3
28
45
7
1
35.9
53.6
72.3
52.2
47.2
52.6
72
75
42.4
53.2
72.2
55.6
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eral trend of increasing H. pylori positive rate with in-
creasing age. The H. pylori positive rate was 42.4% in
those aged 20 years or under, 53.2% in those aged 21
to 30 and 72.2% in those aged between 31 to 40 years.
There was no statistical significance difference of the
H. pylori positive rate detected between males and
females in each age group (all p values were higher
than 0.25).
Discussion
Histological evidence of H. pylori infection was found
in 29/30 (97%) and 35/68 (51.5%) of patients with
duodenal ulcer disease and non-ulcer dyspepsia re-
spectively. These results are very similar to previous
reports.10-12 The GAP-IgG ELISA had an overall sensi-
tivity of 84% and specificity of 85% for detecting H.
pylori infection in this study. The results were disap-
pointing and certainly inferior to those claimed by
the manufacturer (sensitivity 99.4% and specificity
93.5%). It was not clear why there was such a marked
discrepancy. However, we have had similar experi-
ence with another commercial ELISA (Helico-G
ELISA, Porton Cambridge, U.K.).13 We believe the
variation of the sensitivity and the specificity results
in different studies is almost inevitable because the
study populations are different. It is believed that the
variation in antibody recognition of the employed H.
pylori antigens is predominantly host mediated rather
than a reflection of antigenic differences between in-
fecting strains.14 However, there has been claims of
the presence of antigenic variation within the species
which could prevent the detection of antibody re-
sponses in those patients infected with the
less-common variants.14, 15 Although the diagnostic
accuracy of ELISA is inferior to the urea breath test16
(which is probably the most sensitive, and non-inva-
sive but the most expensive test) for confirming H.
pylori infection it is however the most convenient,
economical and acceptable method for epidemiologi-
cal studies. In a study such as this, it serves the purpose
well enough because it gives us an overall idea of the
H. pylori carrier rate in Hong Kong.
Hong Kong has always been regarded as a devel-
oped city. We have shown in this study that about
40% of the healthy blood donor had acquired H. pylori
infection by the age of 20. Furthermore, about 50%)
and 70% of the blood donors had serological evidence
of H. pylori infection by the age of 30 and 40 years
respectively. The H. pylori prevalence rate in those over
40 years of age was about 55% which was lower than
what one would have expected because in the major-
ity of previous studies,17-19 there was usually a linear
increase in the H. pylori infection rate with age. The
apparently lower H. pylori positive rate in this group
of people may represent sampling error. Similarly,
the difference of the H. pylori positive rate between the
males (52%) and the females (75%) aged above 40
years was likely a result of the small sample size in
this study. It probably represents the overall reluc-
tance to donate blood above this age in our society.
This level of H. pylori infection in the healthy blood
donors in Hong Kong far exceeds that of other devel-
oped countries but is still lower than the developing
countries.17-19 In the developed countries, the average
prevalence of H. pylori infection rate in the popula-
tion would be around 20% by the age of 20, < 35% by
the age of 30 and < 50% by the age of 40.7, 17-19 On the
other hand, the H. pylori infection rates increased to >
50% by the age of 20 in the developing countries.
More than 75% of the population would have been
infected by the age of 30 in the third world.7, 17-19 The
overall H. pylori prevalence of 54.9% in Hong Kong is
very similar to that in certain parts of China (45.5 to
60%).20-22 However, areas with high gastric cancer rates
in China has a much higher overall H. pylori prevalence
rates.8, 23 Furthermore, the H. pylori positivily rate
reaches as high as near 70% in children under 12
years of age in these areas.24, 25 Unfortunately, we had
no other demographic data to correlate the results
with the socio-economic status, which is one of the
major determining factors l7-19 of H. pylori positivity
rate, of these blood donors. Blood donors in Hong
Kong are likely to have come from the middle or
upper social class. Hence, the results in this study
may have underestimated the overall H. pylori
prevalence rate in the general population of Hong
Kong.
In this study, we did not detect any difference in
the H. pylori infection rate between males and females
at all age bands. However, there is an increased inci-
dence of peptic ulceration in males when compared
with the females in Hong Kong. According to our
recent study, the male:female ratio for duodenal ulcer
and gastric ulcer disease in Hong Kong is 2.6:1 and
2.1:1 respectively (manuscript in preparation).
Clearly, there is more than one permissive factors,
e.g., acid hypersecretion and ingestion of non-steroidal
anti-inlammmatory drugs, in the development of
peptic ulceration.26 The fact that H. pylori infection is
found in 97% of the duodenal ulceration patients when
compared with only 51.5% in the non-ulcer dyspepsia
patients supports its important role in the pathogenesis
of duodenal ulcer disease. There are also recent evi-
dence suggesting the relationships between H. pylori
carrier and gastric cancer formation.7, 8 H. pylori infec-
tion is believed to be transmitted by the oral-faecal
route.17 High incidence of familial clustering17 supports
the hypothesis of person-to-person spread. There has
been an overall reduction in the H. pylori infection rate
in recent years.7, 17 It is believed to be attributed to the
overall improvement of the people's living condi-
tions. The latter has improved significantly in recent
298 J Hong Kong Med Assoc Vol. 46, No. 4, December 1994
years in Hong Kong. Therefore, we may expect a
much lower H. pylori infection rate in the younger
generation.
In conclusion, H. pylori infection is common among
the Chinese in Hong Kong. The overall carrier rate
falls between the developing countries and the de-
veloped countries. Furthermore, like other countries,
there is a steady rise of H. pylori carrier rate from un-
der 20 years to 40 years of age.
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